10 Cheap Quality Stocks: MU, TSM, PFE & More👇 Why？
10 Cheap Quality Stocks 👇 Why？
The forward P/E ratio is a valuation metric that compares a company’s current stock price to its expected future earnings per share, typically over the next 12 months. It indicates how much investors are willing to pay today for $1 of projected earnings. A lower forward P/E may suggest a stock is undervalued or has weak growth prospects, while a higher ratio implies strong growth expectations but could signal overvaluation.
$Micron Technology(MU)$
Core Business & Latest Developments: Micron is a leading provider of memory and storage solutions, specializing in semiconductor manufacturing. It continues to drive innovation in memory technologies to meet growing market demand.
Analyst Target Price Expectations: Analysts have a "Buy" consensus rating on Micron, with an average price target of $90, indicating a potential upside of approximately 25%.
$Unilever PLC(UL)$
Core Business & Latest Developments: Unilever is a multinational consumer goods company, offering a wide range of food, personal care, and home cleaning products. It continues to expand its product portfolio and global market share.
Analyst Target Price Expectations: Analysts have a "Buy" consensus rating on Unilever, with an average price target of $60, indicating a potential upside of approximately 15%.
$Comcast(CMCSA)$
Core Business & Latest Developments: Comcast is a global media and technology company, providing cable, entertainment, and telecommunications services. It continues to expand its streaming services and content library.
Analyst Target Price Expectations: Analysts have a "Buy" consensus rating on Comcast, with an average price target of $80, indicating a potential upside of approximately 20%.
$Pfizer(PFE)$
Core Business & Latest Developments: Pfizer is a multinational pharmaceutical company, focusing on the research, development, and manufacturing of pharmaceutical products. It continues to advance its pipeline of innovative drugs and vaccines.
Analyst Target Price Expectations: Analysts have a "Buy" consensus rating on Pfizer, with an average price target of $60, indicating a potential upside of approximately 25%.
$Taiwan Semiconductor Manufacturing(TSM)$
Core Business & Latest Developments: Taiwan Semiconductor Manufacturing Company (TSMC) is a global leader in semiconductor foundry services, providing advanced process technologies. It continues to expand its capacity and technological leadership.
Analyst Target Price Expectations: Analysts have a "Buy" consensus rating on TSMC, with an average price target of $150, indicating a potential upside of approximately 20%.
$Qualcomm(QCOM)$
Core Business & Latest Developments: Qualcomm is a leading wireless technology company, providing semiconductor and telecommunications solutions. It continues to drive innovation in 5G and IoT technologies.
Analyst Target Price Expectations: Analysts have a "Buy" consensus rating on Qualcomm, with an average price target of $160, indicating a potential upside of approximately 30%.
$AbbVie(ABBV)$
Core Business & Latest Developments: AbbVie is a global biopharmaceutical company, specializing in research-based drug development. It continues to strengthen its portfolio of pharmaceutical products.
Analyst Target Price Expectations: Analysts have a "Buy" consensus rating on AbbVie, with an average price target of $140, indicating a potential upside of approximately 25%.
$Amgen(AMGN)$
Core Business & Latest Developments: Amgen is a leading biotechnology company, specializing in the discovery, development, and manufacturing of biopharmaceutical products. It continues to advance its pipeline of innovative biologics.
Analyst Target Price Expectations: Analysts have a "Buy" consensus rating on Amgen, with an average price target of $300, indicating a potential upside of approximately 20%.
$Thermo Fisher Scientific(TMO)$
Core Business & Latest Developments: Thermo Fisher is a global leader in life sciences and diagnostics, providing laboratory equipment, reagents, and services. It continues to expand its product offerings and market presence.
Analyst Target Price Expectations: Analysts have a "Buy" consensus rating on Thermo Fisher, with an average price target of $700, indicating a potential upside of approximately 25%.
$Abbott Laboratories(ABT)$
Core Business & Latest Developments: Abbott Laboratories is a global healthcare company, providing medical devices, diagnostics, and nutritional products. It continues to enhance its product portfolio and expand its global presence.
Analyst Target Price Expectations: Analysts have a "Buy" consensus rating on Abbott Labs, with an average price target of $150, indicating a potential upside of approximately 20%
For SG users only, A tool to boost your purchasing power and trading ideas with CashBoost!
Open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here.
Other helpful links:
.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
